Abstract: This report details the main findings of research of latest available data concerning epidemiological status of human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS) and M. tuberculosis (MTB) infections as well as HIV/MTB co-infection in support of Russian Federation (RF) Country Report for the EUCO-Net project on global cooperation in the field of HIV and MTB. In addition to epidemiological analysis this report presents the list of publications concerning epidemiological researches of referred above infections in RF and some other information. The research was undertaken in the period from 2008 to March 2010. The report concludes that the number of tuberculosis (TB) patients with HIV in RF is not great, but is rapidly growing and enhancement of efforts directed on fight against this co-infection are crucially needed.
BACKGROUND
Co-infection with multiple pathogens represents a major threat to human health on a global scale. One of deadly combination is the co-infection HIV with MTB [1, 2] . It is estimated that approximately one quarter (11 million) of the global population infected with HIV are co-infected with MTB [3] . The problem consists that the background of HIV results in immune dysfunction that leads to the reactivation from latent to active tuberculosis or to increase the likelihood of developing active disease after exposure to MTB bacilli. As a consequence, TB-mortality is about four-folder higher amongst HIVseropositive than in seronegative patients [4] . Epidemiological situation of HIV/MTB co-infection illustrates the dimension of the associated health problems. In general, MTB and other Mycobacteria are the most common HIV-related opportunistic infection worldwide and represent the leading cause of mortality in HIV-infected patients, both in adults and children [5] . Management of this public health problem is further complicated due to difficulties with the early diagnostics active TB especially in HIV-infected patients because conventional skin tests as a rule yield the negative outcome on the background of depressed immunity [6] . One more relevant problem is the complex interactions between antiviral and antibacterial therapy. Vivid example is immune reconstruction inflammatory syndrome (IRIS), which is characterized by clinical deterioration during anti-retroviral therapy (ART) that is thought to be due to an immunopathological reaction to MTB as MTB-specific immune response improve [7] .
It is obvious that there is urgent necessity for increased knowledge of the pathogenesis HIV/MTB co-infection and intensified research to explore ways to reduce TB transmission and TB reactivation in people with HIV [8] .
*Address correspondence to this author at the D. I. Ivanovsky Institute of Virology, Russian Academy of Medical Sciences, Russia; Tel: +7(499)1903048; Fax: +7(499)1902867; E-mail: karamov2004@yandex.ru Several international and domestic efforts have been made in Russia over the last time to control this dual epidemic. Some success has been achieved, but much more needs to be done.
DEMOGRAPHIC SITUATION IN THE RUSSIAN FEDERATION
The last population census in RF was passed in 2002 (www.perepis2002.ru). By its outcomes, the permanent population has compounded 145.3 million persons, but after that quantity of citizens was diminished to 141.9 million persons by the first half of 2009. According to Federal State Statistics Service (FSSS) of RF (www.gks.ru) for 1 January 2010 the population has compounded 141297 thousands persons [9] . Besides, according to Federal Migratory Service (FMS) of RF (www.fms.gov.ru) annually 20 million labour migrants comes to RF [10] .
The estimated death rate in RF for 2009 is 14.2 persons per 1000 against the world average of 9 per 1000. The annual birth rate is 12.4 per 1000 (FSSS). The population of RF is significantly urbanized. According to census of 2002, 73% of Russians are city dwellers, 27% -villagers. Also, the significant prevalence of quantity of women in comparison with quantity of men (53.4% of women in overall population) that typical to Russia has been recorded. In addition, the excess of number of aged persons over number of children (18.1% of children in overall population, 61.3% -working-age population, 20.5% -older an able-bodied age) has been registered.
EPIDEMIOLOGICAL ANALYSIS
The research examined the most up-to-date epidemiological data released by the World Health Organization (WHO, www.who.int) [11] , the Joint United Nations Programme on HIV/AIDS (UNAIDS, www.unaids.ru, www.una ids.org) [12] , United States Agency for International Development (USAID, www.usaid.gov) [13] , Russian Federal AIDS Center (RFAC, www.hivrussia.org) [14] and Russian Ministry of Health and Social Development (MoH & SD RF, www.minzdravsoc.ru) [15] .
Basic Epidemiological Data on TB
Substantial changes regarding registered TB incidence were noted in Russia in the last 20-25 years. Gradual decrease of incidence rate till 34,0 per 100 thousand population in the years 1970-1980 changed to considerable growth during 1991 to 2000 and reached 90,7 (2,7 times more) with subsequent stabilization in the first years of the new century at the level of 82-84 per 100 thousand population (see Figs. 1, 2 ) [16] .
TB prevalence among the population is an important cumulative indicator of an overall performance on treatment and surveillance efficiency of TB patients.
TB prevalence rate which is the important indicator of the epidemiological situation is defined as the number of patients, who at the end of the year are still considered to be TB patients per 100 thousand populations [17] .
Recently close attention has been paid to the problem of MDR-TB prevalence. High level of MDR-B makes serious impact on TB spread by way of accumulating of sources of infection in population because of treatment efficiency decrease. Fast spread of HIV infection in Russia affects TB prevalence rate as well.
Today in Russia for TB control the extensive indicators showing the share of MDR-TB patients among various types of patients are used.
HIV infection in Russia has been registered since 1987 [18] . Since then TB has been revealed in HIV-infected patients. The data on TB-cases among HIV-infected has been included in state statistical surveillance form since 1999.
Introduction of unified record and coordination of TB aid to HIV-infected patients affected increase of registered cases with associated infection [19] .
Coverage by screening examination of HIV infection out of new TB patients in 2007 made 90, 9%.
The all-Russian prevalence indicators on TB associated with HIV infection reflect only the situation in Russia on the whole while the data from separate subjects of federation (regions) can differ considerably from each other and from the all-Russian data as well [20] (Table 1) .
Risk groups number makes essential impact on TB epidemiological indicators too. In Russia distinguish 2 risk groups:
Social: homeless; refugees; migrants; being in or released from penitentiary institutions; persons living in shelters, doss-houses, retirement homes; patients in narcological and psychiatric institutions.
Medical:
HIV-infected patients, patients with professional lung diseases because of dust, pancreatic diabetes, peptic ulcer (including operated patients), patients receiving corticosteroid, cytostatic or radiological therapy, patients with radiographic posttuberculous changes.
In accordance with the order of MoH & SD RF the persons from the risk groups undergo additional annual TB examination, however this is not always possible because of their social vulnerability.
The data on TB patients results on the DOTS strategy recommended by WHO is presented in Table 2 . DOTS strategy has been adapted to the conditions of Russia and implemented in all regions of Russia according to the order of MoH & SD RF since 2003. According to the reporting system accepted in RF on the treatment results, the analysis includes the data on the patients who have interrupted treatment, died (from TB and other diseases) and discharged patients (see Fig. 3 ).
In RF MDR-TB dissemination growth differs both in newly detected patients and earlier treated.
Extent of dissemination of MDR-TB differs substantially in different regions of RF.
HIV/AIDS Epidemic
The HIV/AIDS epidemic in RF is one of the fastest growing in the world. Many specialists consider Russia as a new epicenter in global HIV/AIDS pandemic (see Table 4 the true number is somewhere between 1.5 and 2.0 million citizens, or over 2 percent of the adult population.
The epidemic is growing fastest among young people aged 15-30, the very same group that should be leading Russia into the 21 st century. In December 2006, 77.9% of the total number of HIV-positive cases was registered in this age group (see Table 2 Over the past decade, HIV transmission in Russia has been concentrated within a number of high-risk populations, among which there is considerable overlap: injecting drug users, sex workers and prisoners (see Fig. 7 ). Men who have sex with men and migrant workers, especially those from Central Asia, are additional populations with high concentration of HIV. The future of Russia's HIV/AIDS epidemic will turn on the degree to which high risk groups serve as "bridge populations" for transmitting the virus into the heterosexual, nondrug using population. Notable indicators that this shift is already underway include the rapid rise in curable sexually transmitted infections in the general population over the last several years (see Fig. 7 ).
Since the early of 1990's, the drug use in Russia has exploded. There is a direct connection between injecting drug use and HIV. According to numerous studies, drug users in Russia represent a larger share of the total population when compared to other countries (see Fig. 7 and Table 3 ). HIV has already begun moving rapidly from this sub-culture to people who have no direct contact to drugs, often through unprotected sex.
Sex workers constitute a second important high-risk group with the potential to spread HIV into the general population. Since the collapse of the Soviet Union, sex work in Russia has increased dramatically. In Moscow, the number of professional sex workers is believed to total between 20.000 and 40.000. In St. Petersburg, the number of full-time prostitutes is estimated at 10.000. 
HIV/MTB Co-Infection
According to WHO and MoH & SD RF the number of TB patients with HIV in RF is currently small, but the number is rapidly growing. Thus, TB had been diagnosed in Fig. 8 ).
For instance, in Kaliningrad oblast, this number almost doubled in 2003 compared to 2001 (89 cases versus 48).
Over 80% of these cases of TB co-infection were detected at early stages of HIV. The patients are mainly intravenous drug users (89%) and/or the homeless (68%). An analysis of patients who died of AIDS revealed that 53% had TB. Given the average "lag" of six to seven years following the HIV epidemic, a sharp increase in TB incidence should be expected by next time. WHO predicts that the a third of the HIV-positives will develop TB during their lifetime and gives several reasons to this [24] :
HIV increases the risk of MTB infection, HIV promotes progression to active TB in people with recently acquired and with latent MTB infection, Increasing TB cases in people living with HIV results in an increased risk of TB transmission to the general public, HIV increases risk of recurrent TB.
STATE OF THE ART IN RESEARCH
All in all about 7 000 publications on TB including HIVassociated TB were published in RF during 2000-2008. The most significant and best known are the following (in chronological order):
According to the order of MoH & SD RF 89 regions of Russia are divided into areas of supervision between 5 institutes: Central TB Research Institute of RAMS, Moscow research institute of Phthisiopulmonology named after I.M. Sechenov, Novosibirsk, Ural and St.-Petersburg TB institutes. The named above institutes function as reference centres and supervise the territories of the Russian Federation, on their basis operate the units (Centres) on drug resistant TB treatment, clinical and diagnostic departments, microbiological laboratories of the 3-rd level and the base to perform organizational and methodical work. The institutes supervise the territories, i.e. provide organizational and methodical, educational, consultative and diagnostic support through regional TB dispensaries which are responsible for all the work on TB in the region.
Besides, the "Coordination Board" and the "Centre on TB-aid to HIV-infected patients" of MoH & SD RF were set up in accordance with the "Programme of activities on TBaid to HIV-infected patients". In each territory operates a coordinator on HIV-associated TB, who is a member of the Board. Patients with AIDS undergo (in diagnostics centre at AIDS Center) scheduled TB examination. In his turn a phthisiatrician of a TB dispensary monitors HIV-infected and patients with HIV/MTB co-infection. University of Medicine and Dentistry of New Jersey a) "TB/AIDS Control Project" includes the following two key components: ( ) "Tuberculosis" and ( ) "AIDS". It will be implemented at the federal and regional levels in the health care and FPS institutions of Russia. The Project covers 86 regions of the Russian Federation. It has the following objectives: (i) to facilitate control over the epidemic spread of TB and AIDS for a short-term outlook and (ii) to stabilize and reduce these epidemic diseases' levels -for a medium-term outlook. The TB component provides for the establishment of a basis for TB high-quality diagnostics, treatment and epidemiological monitoring. It will cover at least 50% of civilian population and 100% of populations in penitentiary institutions. It is planned to additionally provide for about 3000 diagnostic laboratories of different levels. The AIDS component provides for the supply of laboratory and medical equipment to the federal and regional HIV/AIDS services (90 laboratories in the civilian sector and 10 laboratories of the penitentiary system of Russia) and STI services (20 centers). It is planned to improve epidemiological surveillance and monitoring, conduct campaigns on HIV/AIDS and STI prevention for communities and high-risk groups of population, and to provide material and technical support for 6 or 7 blood transfusion stations, to strengthen two federal consulting and diagnostic center for HIV-exposed children, including medical equipment and drugs for pregnant HIV-exposed women (2500) and newborn children (150).
b) The National Priority Project "Health": Carrying out of actions for preventive maintenance, revealing and treatment of some diseases (HIV-infection, hepatitis B, rubella).
Definition of a number of HIV-infected of the citizens who are subject to treatment, definition of requirement for special medicines, tests for diagnostics and the control of efficiency of treatment of HIV-infection. Carrying out of actions for prevention of expansion of HIV-infection, hepatitis B and C in the groups of the population most predisposed to infection.
DIAGNOSTIC STANDARDS
In accordance with regulating documents (orders of MoH & SD RF) the standard minimum of investigations obligatory for TB diagnosis and also a number of additional and facultative methods of examination which are performed if necessary for diagnosis specification are defined in Russia.
Obligatory standard diagnostic methods at primary health institutions, at the stage of diagnostics: clinical trial, ZiehlNeelsen sputum smear microscopy (not less than 3 tests with quantitative estimation of SS+ (bacterioexcretion), chest Xray, clinical blood test, Mantoux test with 2 PPD-L at complaints of TB suspect patients or at scheduled examination (1 time annually) of the persons in risk groups.
Obligatory standard diagnostic methods in TB institutions, at the stage of diagnostics: clinical trial; ZiehlNeelsen sputum smear microscopy (not less than 3 tests with quantitative estimation of SS+ (bacterioexcretion), chest Xray; and other methods of radiological diagnostics, Mantoux test with 2 PPD-L, detection of SS+ (culture positive) on solid media; drug susceptibility testing on solid media.
Additional methods of investigation: extended microbiological diagnostics (PCR-diagnosis of sputum and fluorescence sputum smear microscopy at negative Ziehl-Neelsen microscopy); sputum inoculation on liquid media and M. tuberculosis drug susceptibility testing by BACTEC MGIT 960; M. tuberculosis drug susceptibility testing to R, H, Ft on biological microchips; PCR (polymerase chain reaction). Diagnostic standards conform to WHO diagnostic standards.
Profound (advanced) radiological diagnostics (computerized axial tomography (CAT), ultrasonic scanning and other);
Immunodiagnostics (immune-enzyme analysis H 37 RV, TB antibodies and antigens detection, evaluation of T and Blymphocytes quantity and functional activity and their regulatory subpopulations (helpers and suppressors), evaluation of phagocyte system functional activity, immunologic tests with chemo agents and other;
Bronchi examination (bronchoalveolar lavage, different biopsy procedures);
Other invasive methods (video thoracoscopy, pleuroscopy (thoracoscopy), mediastinoscopy, thoracotomy and other with biopsy material (tissue sampling) study with cytologic and histilogic techniques); Lungs and cardiovascular system functioning examination, biochemical investigations (liver, kidney functions, blood coagulant system, lipid peroxidation, protein metabolism, etc.)
MEDICAL TREATMENT STANDARDS
Treatment of TB patients at hospitals and at out-patient stages on the territory of RF is conducted in accordance with the orders of MoH & SD RF. Treatment of TB caused by drug sensitive M. tuberculosis is realized according to DOTS regimen (regimens 1, 3, 2(A)) (see Table 7 ). 
SCIENTIFIC CHALLENGES FOR THE FUTURE

No.
Project Name Results to be Obtained
1.
Studying molecular epidemiology of M. tubeculosis with primary and acquired MDR and XDR in various CIS countries (Russia, Azerbaijan, Uzbekistan, Moldova, Belarus, Kazakhstan).
New and correct data on drug resistant TB prevalence rate including MDR will be obtained.
Recommendations on adequate treatment regimens of patients at the initial stage of treatment with no available data on drug resistance of strains (on the average, up to 2 -3 months), and also for SS negative patients will be developed. Recommendations to enhance National TB Programs will be prepared.
Articles, reports.
Implementation level -federal.
2.
Further study of molecular-biological properties of . tuberculosis strains of W cluster.
The data characterizing the peculiarities of . Tuberculosis strains of W cluster, reflecting possible advantages of the given cluster will be obtained.
. Tuberculosis belonging to W family will be characterized according to several parametres (microbiological and moleculargenetic).
3.
Working out new gene technologies for fast identification of M. tuberculosis and detection of their drug resistance.
New data on M. tuberculosis genome and mechanism of M. tuberculosis resistance formation to TB drugs will be obtained. New biological microchips detecting M. tuberculosis resistance to 1-st and 2-nd line drugs will be developed and tested. Also the masspectrometry technique to reveal M. tuberculosis drug resistance will be adapted.
4.
Study of TB epidemiology on the territory of the Russian Federation using molecular and genetic technologies.
Data on prevalence of M. tuberculosis certain strains on the territory of the Russian Federation will be obtained, channels of infection will be detected and reasons for TB outbreak will be investigated.
Creation of the bank of strains and data storage.
Adaptation of accelerated technology of spolygotyping using microchip technology.
Test-system to carry out accelerated spolygotyping on biological microchips will be developed.
5.
Study of intracellular growth of M. tuberculosis strains of various genotypic clusters in in vitro model when infecting peritoneal macrophages of mouse.
The data characterizing the peculiarities of interaction of mycobacterium strains with cells of the host, dependence of a phenomenon on genetic-mediated expression of virulence factors will be obtained.
Characteristics of growth and cytopathogenic effect of mycobacteria of various clusters phagocyted by macrophages will be studied.
Estimation of expression of virulence genes and persistence of mycobacterium phagocyted by macrophages will be given.
Can be used to create TB drugs with the new mechanism of action.
6.
The role and study of surfactant system in pathogenesis of pulmonary TB.
Evaluation of state of pulmonary surfactant and alveolar macrophages under sharp pulmonary TB progression will be given.
Effect of various combinations of TB drugs on surfactant production by alveolocytes of the 2nd type will be studied.
Possibility of activation of surfactant system of the lung changed as a result of TB by pharmacological drugs and exogenous surfactant will be studied.
7.
Molecular-genetic investigations of genes determining hereditary predisposition to mycobacterial diseases
The genetic markers determining predisposition to TB will be detected.
Our knowledge on functioning of the general immune mechanisms of stability to mycobacterial pathogen will be expanded.
Computer databank and bank of DNA samples from patients and healthy people will be generated.
Computer databank and bank of DNA samples from patients and healthy people will be supplemented. Probable models of genetic stability to TB will be developed, general genetic markers of the studied genes for TB and leprosy sensitivity will be detected.
Setting up of genetic consultation centre regarding predisposition to mycobacterial diseases.
8.
Studying the impact of the genes of chromosome 6 of a man on sensitivity to tuberculosis
Our knowledge on functioning of the general immune mechanisms of stability to mycobacterial pathogen will be expanded and mutations of genes determining susceptibility to TB will be detected.
Complexes of genetic markers according to HLA system and genes PARK2 and PACRG including extensive haplotypes and genotypic combinations in connection with sensitivity to TB will be studied.
Articles, reports 9.
IgG response in pulmonary TB patients: subclass studies.
The goal of this study is evaluation of IgG antibodies belonging to distant subclasses in pulmonary TB patients in order to establish their possible roles in TB course.
Anticipated results of the IgG isotypes' studying will be superposed dynamically against the observed clinical TB symptoms and the efficacy of drug treatment. Development of the IgG isotypic responses against individual mycobacterial antigens will be evaluated with regard to the parallel shifts in the expression of differentiation factors involved in the CD4 + cells development, as well as production of several cytokines. We also plan to evaluate isotype-specific local IgG responses in the lung tissue. As a practical aspect, we plan to create new preparations of anti-human IgG isotype-specific monoclonal antibodies potentially useful for TB serodiagnosis.
10.
Establishment of specific molecular vectors useful for transportation of anti-TB drugs towards TB foci.
The goal of this study is to create on the basis of anti-TB monoclonal antibodies (mAbs) molecular tools able to carry drugs towards TB foci. The established assembled preparations will be studied with regard to their efficacy against mycobacteria in vitro and in vivo. We plan to develop mAbs specific for the protease and glycosidaseresistant surface mycobacterial antigens. These mAbs will be conjugated with anti-TB drugs. The object of the study: intracellular anti-TB therapy. Practical aspect: development of new tools delivering drugs into TB foci.
Major Research Topics Remarks
1. Experimental revision of approaches to creation of a vaccine against HIV on the basis of different mechanisms of the virus penetration.
There is a proved opinion that dynamics of a HIV infection and genetic transformation of a virus in the individual is essentially various at sexual contact (mucous membrane) and at injection (the heroin use). In Russia the main social group subject to HIV infection, hepatitises and tuberculosis are heroin addicts (more than 60%). 
National (and Bilateral) Funding Programs
Mechanisms of inhibition of viral replication by plant polyphenols [26] Russian Foundation for Basic Research Development of methods of complex laboratory researches of applicant (potential, challenging, prospective, promising) vaccines against HIV/AIDS on the basis of recombinant proteins [25, 28] The 
INTERCULTURAL SENSITIVITIES
The unified system of TB activities (TB and TB/HIV prophylaxis, detection, diagnostics and treatment) and unified reporting and accounting documentation which are regulated by the orders of MoH & SD RF are adopted in the Russian Federation.
National features of mentality of various ethnic nationalities living in the Russian Federation can become apparent only in their relation to these activities.
Intercultural differences and sensitivities
Intercultural differences and sensitivities in Russia are insignificant. At least in the field of public health services.
Site specific policies
Officially usual European policies take place.
Practically a considerable arbitrariness of officials and corruption takes place. 
CONCLUSION AND REFLECTIONS
The first years of the 21st century are characterized in the Russian Federation by certain stabilization of the basic epidemiological TB rates and indicators showing efficiency of TB activities. At the same time the situation remains serious enough.
Numerous factors affecting TB dissemination demand thorough study. The problem of HIV-associated TB is of great importance to Russia.
Prevalence growth of associated infection can cause serious damage to population health of the country when appropriate activities are not carried out.
In order to enhance monitoring of HIV-associated TB it is essential to introduce everywhere a uniform system of registration of cases with associated infection.
Thus, TB situation in the Russian Federation is complicated enough and the necessity to further enhance TB control performance and implement modern methods to stop the disease prevails.
Development and implementation of new diagnostic and medical technologies offer major challenge. To achieve this, thorough support of scientific research activities and projects is vital. Here, it is important to rely on both wide experience of the Russian phthisiology and international experience, including the neighbouring European countries. There is evident correlation between TB and AIDS. Results of investigations in number of developing countries shows that about 70% TB-infected have HIV. More over, about 50% HIV-infected have high risk to get developing of TB in view weakening of immune system. TB is being the main accompanier of AIDS among more than half of all HIV-infected in developing countries where live about 95% per cent of all HIV-infected. In industrial countries there is observing signs of revival TB because of spreading AIDS.
REFLECTIONS
TB is one of the main death reasons of HIV-infected. The more per cent of HIV-infected in country, the more level of deaths from TB.
There is problem of early diagnostic of TB and AIDS. TB-infected patients have high per cent of destructed lung tissue and being source of infection for long. Among first diagnosed TB-infected there is low virus load and some diagnostic systems are not sensitive to them. Also one of the main problem is high genetic variability of HIV and multidrug resistant of HIV and MTB.
Strengthening international collaboration on therapies, a cure, and a vaccine and mobilizing world resources, scientists and international organizations in the fight against AIDS will help in struggle against AIDS and TB.
About 13 million people in the world are being carries of HIV and MTB at the same time. TB like usual catarrhal disease transmits airily. Struggle against AIDS/TB is the problem of world health and world society.
The cumulative number of the registered citizens with HIV infection is 448 thousand. Number of the citizens infected with MTB is about 290 thousand. At first sight it is not a catastrophic picture. However, the situation in Russia sharply differs from a situation in other countries. Contamination with HIV among the registered addicts is 74%. Their approximate quantity is 400 thousand. The quantity of not registered consumers of heavy drugs is 3 times more. Contamination with MTB among not registered addicts is extremely high and they do not visit medical institutions. Our estimation of quantity of addicts of simultaneously infected with HIV and MTB makes from 20 to 100 thousand. The problem is extremely serious. 
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